Key result
Anticancer treatments, including chemotherapy, targeted therapy, and immunotherapy, are associated with common and potentially life-threatening cardiovascular toxicities such as heart failure.
Why the study?
Current oncologic treatments have improved overall cancer survival, but cardiac toxicities from chemotherapy, targeted therapy, and immunotherapy can cause life-threatening side effects.
What are the mechanisms, epidemiology, and management strategies for cardiovascular toxicities associated with anticancer treatments?
Design
Review
Authors
Loading...
Cardio-oncology vigilance is warranted with expanding cancer therapies; review leaves open standardized prevention and monitoring protocols.
What are the mechanisms, epidemiology, and management strategies for cardiovascular toxicities associated with anticancer treatments?
This review emphasizes the importance of a multidisciplinary cardio-oncology approach to manage the common and potentially life-threatening cardiovascular toxicities of modern cancer therapies.
Zarifa et al. (2019) conducted a review in Cancer. Anticancer treatments was evaluated on Cardiovascular toxicities. Anticancer treatments, including chemotherapy, targeted therapy, and immunotherapy, are associated with common and potentially life-threatening cardiovascular toxicities such as heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: